203 related articles for article (PubMed ID: 9395230)
21. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma.
Goldstein SR; Yang GY; Chen X; Curtis SK; Yang CS
Carcinogenesis; 1998 Aug; 19(8):1445-9. PubMed ID: 9744541
[TBL] [Abstract][Full Text] [Related]
22. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
23. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma.
Li Y; Wo JM; Su RR; Ray MB; Martin RC
Ann Surg Oncol; 2007 Jul; 14(7):2045-55. PubMed ID: 17473952
[TBL] [Abstract][Full Text] [Related]
24. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
25. From Reflux Esophagitis to Esophageal Adenocarcinoma.
Souza RF
Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
[TBL] [Abstract][Full Text] [Related]
26. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
[TBL] [Abstract][Full Text] [Related]
27. Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
Kelly RJ; Ansari AM; Miyashita T; Zahurak M; Lay F; Ahmed AK; Born LJ; Pezhouh MK; Salimian KJ; Ng C; Matsangos AE; Stricker-Krongrad AH; Mukaisho KI; Marti GP; Chung CH; Canto MI; Rudek MA; Meltzer SJ; Harmon JW
Ann Surg; 2021 Jun; 273(6):e206-e213. PubMed ID: 31290765
[TBL] [Abstract][Full Text] [Related]
28. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
[TBL] [Abstract][Full Text] [Related]
29. Duodenal juice stimulates oesophageal stem cells to induce Barrett's oesophagus and oesophageal adenocarcinoma in rats.
Miyashita T; Ohta T; Fujimura T; Ninomiya I; Fushida S; Hattori T; Miwa K
Oncol Rep; 2006 Jun; 15(6):1469-75. PubMed ID: 16685381
[TBL] [Abstract][Full Text] [Related]
30. Animal Model: Reflux Models in Esophageal Adenocarcinoma.
Masuda T; Mittal SK
Methods Mol Biol; 2018; 1756():143-150. PubMed ID: 29600367
[TBL] [Abstract][Full Text] [Related]
31. Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats.
Pera M; Brito MJ; Poulsom R; Riera E; Grande L; Hanby A; Wright NA
Carcinogenesis; 2000 Aug; 21(8):1587-91. PubMed ID: 10910963
[TBL] [Abstract][Full Text] [Related]
32. [Reflux of duodenal or gastroduodenal contents induces esophageal carcinoma in rats].
Miwa K; Miyashita T; Hattori T
Nihon Rinsho; 2004 Aug; 62(8):1433-8. PubMed ID: 15344531
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
34. Columnar metaplasia in the esophageal remnant after esophagectomy: a systematic review.
Dunn LJ; Shenfine J; Griffin SM
Dis Esophagus; 2015 Jan; 28(1):32-41. PubMed ID: 24224923
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans.
Chen X; Ding Y; Liu CG; Mikhail S; Yang CS
Carcinogenesis; 2002 Jan; 23(1):123-30. PubMed ID: 11756233
[TBL] [Abstract][Full Text] [Related]
36. [Carcinogenesis of Barrett's esophagus].
Endo T; Sugawara N; Shinomura Y
Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
[TBL] [Abstract][Full Text] [Related]
37. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 (COX-2) is the key event in pathophysiology of Barrett's esophagus. Lesson from experimental animal model and human subjects.
Majka J; Rembiasz K; Migaczewski M; Budzynski A; Ptak-Belowska A; Pabianczyk R; Urbanczyk K; Zub-Pokrowiecka A; Matlok M; Brzozowski T
J Physiol Pharmacol; 2010 Aug; 61(4):409-18. PubMed ID: 20814068
[TBL] [Abstract][Full Text] [Related]
39. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
Ozcan HEA; Anuk T; Ozden O
Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
[TBL] [Abstract][Full Text] [Related]
40. Impact of inflammation-metaplasia-adenocarcinoma sequence and inflammatory microenvironment in esophageal carcinogenesis using surgical rat models.
Miyashita T; Tajima H; Shah FA; Oshima M; Makino I; Nakagawara H; Kitagawa H; Fujimura T; Harmon JW; Ohta T
Ann Surg Oncol; 2014 Jun; 21(6):2012-9. PubMed ID: 24526548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]